We are live on ! Find out more
BRA

Bender Robert & Associates Portfolio holdings

AUM $417M
1-Year Est. Return 25.02%
This Fund
S&P 500
This Quarter Est. Return
-18.34%
1 Year Est. Return
+25.02%
3 Year Est. Return
+98.12%
5 Year Est. Return
+139.29%
10 Year Est. Return
+812.75%
AUM
$173M
AUM Growth
-$46.7M
Cap. Flow
-$3.8M
Cap. Flow %
-2.19%
Top 10 Hldgs %
59.78%
Holding
48
New
Increased
2
Reduced
42
Closed
2

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$2.79K
2
NEE icon
NextEra Energy
NEE
+$1.75K

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$539K
2
EXEL icon
Exelixis
EXEL
+$398K
3
SLB icon
SLB Ltd
SLB
+$295K
4
ILMN icon
Illumina
ILMN
+$288K
5
MELI icon
Mercado Libre
MELI
+$229K

Sector Composition

Rank Sector Weight
1 Healthcare 34%
2 Consumer Discretionary 26.66%
3 Technology 23.64%
4 Communication Services 11.02%
5 Industrials 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVDA icon
26
NVIDIA
NVDA
$4.76T
$1.75M 1.01%
523,520
-112,680
-18% -$539K
BA icon
27
Boeing
BA
$167B
$1.46M 0.84%
4,534
-38
-0.8% -$13.1K
HD icon
28
Home Depot
HD
$335B
$892K 0.52%
5,190
-15
-0.3% -$2.69K
NEE icon
29
NextEra Energy
NEE
$185B
$808K 0.47%
18,600
+40
+0.2% +$1.75K
ABT icon
30
Abbott
ABT
$182B
$801K 0.46%
11,071
-220
-2% -$15.5K
NSC icon
31
Norfolk Southern
NSC
$77.1B
$692K 0.4%
4,627
-58
-1% -$9.54K
LLY icon
32
Eli Lilly
LLY
$1.07T
$644K 0.37%
5,568
+25
+0.5% +$2.79K
JNJ icon
33
Johnson & Johnson
JNJ
$641B
$624K 0.36%
4,835
-25
-0.5% -$3.49K
BMY icon
34
Bristol-Myers Squibb
BMY
$128B
$612K 0.35%
11,771
-409
-3% -$22K
PFE icon
35
Pfizer
PFE
$141B
$556K 0.32%
13,435
-79
-0.6% -$3.28K
MRK icon
36
Merck
MRK
$323B
$487K 0.28%
6,673
-21
-0.3% -$1.48K
JPM icon
37
JPMorgan Chase
JPM
$947B
$410K 0.24%
4,204
-70
-2% -$7.46K
T icon
38
AT&T
T
$167B
$384K 0.22%
17,810
-159
-0.9% -$3.7K
PAYX icon
39
Paychex
PAYX
$41.1B
$337K 0.19%
5,180
NUE icon
40
Nucor
NUE
$56.4B
$287K 0.17%
5,546
-60
-1% -$3.55K
COST icon
41
Costco
COST
$422B
$284K 0.16%
1,395
-30
-2% -$6.7K
VZ icon
42
Verizon
VZ
$198B
$262K 0.15%
4,669
-15
-0.3% -$851
TROW icon
43
T. Rowe Price
TROW
$25.5B
$254K 0.15%
2,750
-55
-2% -$5.34K
CAT icon
44
Caterpillar
CAT
$402B
$248K 0.14%
1,949
DUK icon
45
Duke Energy
DUK
$100B
$232K 0.13%
2,686
-25
-0.9% -$2.13K
DE icon
46
Deere & Co
DE
$169B
$215K 0.12%
1,440
-10
-0.7% -$1.47K
CVX icon
47
Chevron
CVX
$378B
-1,845
Closed -$226K
SLB icon
48
SLB Ltd
SLB
$76.5B
-4,837
Closed -$295K

Similar funds

Bender Robert & Associates's Q4 2018 Portfolio in Review

As of Q4 2018, Bender Robert & Associates held 48 positions worth $173M, down 21% from $220M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Trading was light in Q4 2018: portfolio turnover was 4.2%. Bender Robert & Associates opened no new positions and exited 2, leaving the 48-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Bender Robert & Associates added most to Eli Lilly in Q4 2018, an estimated $2.79K increase.
  • Bender Robert & Associates's biggest Q4 2018 reduction was NVIDIA, cutting an estimated $539K.
  • Bender Robert & Associates fully exited SLB Ltd in Q4 2018, selling an estimated $295K.
  • Bender Robert & Associates's ten largest holdings make up 60% of its $173M portfolio in Q4 2018.
  • Bender Robert & Associates opened 0 new positions and closed 2 in Q4 2018.
  • Bender Robert & Associates's portfolio value fell 21% quarter-over-quarter to $173M.

Based on Bender Robert & Associates's 13F filing for Q4 2018, filed 24 Jan 2019.